RAD-140 + MK-677 + YK-11 Value Pack

Buy RAD-140 + MK-677 + YK-11 Value Pack Online

This value pack combines RAD-140, MK-677, and YK-11, bringing together androgen-receptor signaling, growth-hormone secretagogue activity, and experimental myostatin-related research.

Product Information

RAD-140 is a SARM investigated for anabolic activity, MK-677 stimulates GH/IGF-1 pathways, and YK-11 has been studied experimentally in relation to myostatin and muscle-wasting pathways.

How It Works

RAD-140 activates androgen receptors, MK-677 stimulates the ghrelin receptor to increase GH release, while YK-11 has been investigated for effects on myostatin-related signaling. These mechanisms are distinct but all intersect with muscle-growth research.

POTENTIAL BENEFITS

1. Muscle-Growth Research

RAD-140 has demonstrated anabolic activity in preclinical research, while YK-11 has also been investigated in muscle-related experimental models.

2. Lean-Mass Research

MK-677 has produced increases in fat-free mass in human studies, while RAD-140 has demonstrated effects on muscle fiber size in animal research.

3. Growth-Hormone Research

MK-677 increases circulating GH and IGF-1, providing a well-defined research pathway within this combination.

4. Myostatin Research

YK-11 has attracted interest because of experimental findings involving myostatin inhibition and muscle-related signaling.

Dosage

There is no established clinical dosage for this combination. Online protocols vary significantly, and combining these compounds has not been adequately studied in controlled human trials.

Side Effects

Potential concerns include hormonal suppression, increased appetite, fluid retention, glucose changes, liver effects, and other endocrine reactions.

References

• Puskas J, et al. Preclinical assessment of RAD140 to increase muscle mass and bone mineral density. PubMed
• Nass R, et al. MK-677 increases GH secretion, fat-free mass, and energy expenditure. PubMed
• Myostatin inhibitor YK11 as a preventative health supplement for bacterial sepsis. 2021. PubMed

Reference note: The YK-11 evidence is preclinical and does not establish human muscle-building efficacy. The references support the individual components rather than this specific combination.

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Please click here to see how purchases actually work on this site.